Omnicell Inc
OMCL—
Build a strategy around OMCL
Omnicell Inc AI Insights
Informational only. Not investment advice.Snapshot
- Goodwill of 738M is 60% of equity (1.2B) - acquisition-heavy model with impairment risk if growth stalls[Goodwill]
- FCF of 94M TTM vs net income of 20M - 4.7x conversion signals strong cash quality despite weak earnings[Free Cash Flow]
- EPS declined 37% 1Y and 31% 3Y CAGR while P/E at 108x vs industry median 35x - priced for turnaround[P/E Ratio]
Watch Triggers
- Operating Margin: Rises above 3% for 2 consecutive quarters — Would signal turnaround traction; current 1.5% is unsustainable for valuation
- Total Revenue: Returns to positive YoY growth — Revenue decline must reverse before margin expansion can drive earnings
- Goodwill: Any impairment charge announced — 738M goodwill at risk if revenue decline persists; would hit equity hard
Bull Case
FCF yield of 4.4% (94M/2.1B cap) with aggressive debt paydown (-400M TTM) strengthens balance sheet rapidly
Free Cash FlowNet Long-Term Debt Issuance
Low debt/equity of 0.17 and 180M cash provides flexibility for turnaround without dilution risk
Debt to EquityCash and Equivalents
Bear Case
Revenue declining 3.7% 3Y CAGR in healthcare IT - structural demand issue, not cyclical
Total Revenue 3Y Growth
P/E of 108x for a company with -37% EPS growth 1Y requires flawless execution to justify
P/E RatioEPS Growth 1Y
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
35%
Leverage OMCL's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Margin recovery to 5%+ operating margin would re-rate stock materially from current 1.5% level
1-3ylow
- Operating margin TTM 1.5% vs 2% industry median
- R&D at 8% of revenue signals product investment
- Debt paydown of 400M reduces interest burden
Operating income 17M on 1.2B revenue TTMNet long-term debt issuance -400M TTMFCF 94M provides runway for restructuring
Valuation Context
Caveats
Public Strategies Rankings
See how Omnicell Inc ranks across different investment strategies.
Leverage OMCL's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
OMCL Fundamentals
Health Care and Social Assistance → Ambulatory Health Care Services
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$1.55B | — | ||
$1.56B | — | ||
851 | — | ||
$1.18B | +6.5% | — | |
$0.04 | -85.2% | — | |
0.44% | +0.4% | — | |
0.17% | -1.0% | — | |
$69.37M | -48.6% | — | |
0.17% | -0.9% | — | |
Beta 5Y (Monthly) | unknown | — |
OMCL Dividend History
No dividends
OMCL Stock Splits
No stock splits
OMCL SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
02/26/26 | 12/31/25 | 10-K | |
11/05/25 | 09/30/25 | 10-Q | |
08/06/25 | 06/30/25 | 10-Q | |
05/07/25 | 03/31/25 | 10-Q | |
02/27/25 | 12/31/24 | Unknown | |
11/08/24 | 09/30/24 | 10-Q | |
08/06/24 | 06/30/24 | 10-Q | |
05/07/24 | 03/31/24 | 10-Q | |
02/28/24 | 12/31/23 | 10-K | |
11/03/23 | 09/30/23 | 10-Q | |
08/04/23 | 06/30/23 | 10-Q | |
05/05/23 | 03/31/23 | 10-Q | |
03/01/23 | 12/31/22 | 10-K | |
11/04/22 | 09/30/22 | 10-Q | |
08/09/22 | 06/30/22 | 10-Q | |
05/09/22 | 03/31/22 | 10-Q | |
02/25/22 | 12/31/21 | 10-K | |
11/05/21 | 09/30/21 | 10-Q | |
08/06/21 | 06/30/21 | 10-Q | |
05/04/21 | 03/31/21 | 10-Q | |
02/24/21 | 12/31/20 | 10-K | |
10/30/20 | 09/30/20 | 10-Q | |
07/31/20 | 06/30/20 | 10-Q | |
05/08/20 | 03/31/20 | 10-Q | |
02/26/20 | 12/31/19 | 10-K | |
11/01/19 | 09/30/19 | 10-Q | |
08/02/19 | 06/30/19 | 10-Q | |
05/03/19 | 03/31/19 | 10-Q | |
02/27/19 | 12/31/18 | 10-K | |
11/02/18 | 09/30/18 | 10-Q | |
08/03/18 | 06/30/18 | 10-Q | |
05/04/18 | 03/31/18 | 10-Q | |
02/27/18 | 12/31/17 | 10-K | |
11/03/17 | 09/30/17 | 10-Q | |
08/04/17 | 06/30/17 | 10-Q | |
05/05/17 | 03/31/17 | 10-Q | |
02/28/17 | 12/31/16 | 10-K | |
11/07/16 | 09/30/16 | 10-Q | |
08/05/16 | 06/30/16 | 10-Q | |
05/06/16 | 03/31/16 | 10-Q | |
02/26/16 | 12/31/15 | 10-K | |
11/06/15 | 09/30/15 | 10-Q | |
08/07/15 | 06/30/15 | 10-Q | |
05/08/15 | 03/31/15 | 10-Q | |
03/30/15 | 12/31/14 | 10-K | |
11/10/14 | 09/30/14 | 10-Q | |
08/07/14 | 06/30/14 | 10-Q | |
05/12/14 | 03/31/14 | 10-Q | |
03/17/14 | 12/31/13 | 10-K | |
11/08/13 | 09/30/13 | 10-Q | |
08/09/13 | 06/30/13 | 10-Q | |
05/09/13 | 03/31/13 | 10-Q | |
03/11/13 | 12/31/12 | 10-K | |
11/09/12 | 09/30/12 | 10-Q | |
08/09/12 | 06/30/12 | 10-Q | |
05/08/12 | 03/31/12 | 10-Q | |
03/08/12 | 12/31/11 | 10-K | |
11/04/11 | 09/30/11 | 10-Q | |
08/05/11 | 06/30/11 | 10-Q | |
05/10/11 | 03/31/11 | 10-Q | |
03/11/11 | 12/31/10 | 10-K | |
11/08/10 | 09/30/10 | 10-Q | |
08/09/10 | 06/30/10 | 10-Q | |
05/10/10 | 03/31/10 | 10-Q | |
02/24/10 | 12/31/09 | 10-K | |
11/09/09 | 09/30/09 | 10-Q | |
08/05/09 | 06/30/09 | 10-Q | |
05/08/09 | 03/30/09 | 10-Q | |
02/24/09 | 12/31/08 | 10-K | |
11/07/08 | 09/30/08 | 10-Q | |
08/08/08 | 06/30/08 | 10-Q | |
05/12/08 | 03/30/08 | Unknown | -- |
03/17/08 | 12/31/07 | 10-K | |
11/09/07 | 09/30/07 | 10-Q | |
08/09/07 | 06/30/07 | 10-Q | |
05/10/07 | 03/30/07 | Unknown | -- |
03/23/07 | 12/31/06 | NT 10-K | |
11/09/06 | 09/30/06 | 10-Q | |
08/09/06 | 06/30/06 | 10-Q | |
05/10/06 | 03/30/06 | Unknown | -- |
03/16/06 | 12/31/05 | 10-K | |
11/09/05 | 09/30/05 | 10-Q | |
08/09/05 | 06/30/05 | 10-Q | |
05/10/05 | 03/30/05 | Unknown | -- |
03/16/05 | 12/31/04 | 10-K | |
11/09/04 | 09/30/04 | 10-Q | |
08/09/04 | 06/30/04 | 10-Q | |
05/06/04 | 03/30/04 | Unknown | -- |
03/08/04 | 12/31/03 | 10-K | |
11/14/03 | 09/30/03 | 10-Q | |
08/07/03 | 06/30/03 | 10-Q | |
05/08/03 | 03/30/03 | Unknown | -- |
03/28/03 | 12/31/02 | 10-K | |
11/14/02 | 09/30/02 | 10-Q | |
08/13/02 | 06/30/02 | 10-Q | |
05/14/02 | 03/30/02 | Unknown | -- |
03/27/02 | 12/31/01 | 10-K405 | |
11/14/01 | 09/30/01 | 10-Q | |
09/20/01 | 06/30/01 | 10-Q | |
03/31/01 | 03/30/01 | Unknown | -- |